Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
01/06/2015 | US8927715 Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 |
01/06/2015 | US8927711 JAK kinase modulating compounds and methods of use thereof |
01/06/2015 | US8927710 Substituted polycyclic carbamoylpyridone derivative |
01/06/2015 | US8927709 Hepatitis C virus inhibitors |
01/06/2015 | US8927605 Use of physiological cooling active ingredients, and agents containing such active ingredients |
01/06/2015 | US8927588 Imidazole carbonyl compound |
01/06/2015 | US8927587 Chemical compounds |
01/06/2015 | US8927581 Fungicidal N-(2-pyridylpropyl) carboxamide derivatives and their oxa, aza and thia analogues |
01/06/2015 | US8927579 Male contraceptive |
01/06/2015 | US8927572 Crystal form I of salt of a dipeptidyl peptidase-IV inhibitor and preparation method and use thereof |
01/06/2015 | US8927563 Kinase inhibitor |
01/06/2015 | US8927559 Quinazolinone-type compounds as CRTH2 antagonists |
01/06/2015 | US8927551 Isoxazolines as inhibitors of fatty acid amide hydrolase |
01/06/2015 | US8927550 Heterocyclic compounds as CCR1 receptor antagonists |
01/06/2015 | US8927548 Triazole compounds that modulate HSP90 activity |
01/06/2015 | US8927546 Therapeutic piperazines |
01/06/2015 | US8927540 Pyridazinone derivatives |
01/06/2015 | US8927534 Compounds for the inhibition of integrins and use thereof |
01/06/2015 | US8927533 Thio derivatives bearing lactams as potent HDAC inhibitors and their uses as medicaments |
01/06/2015 | US8927530 Therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent |
01/06/2015 | US8927503 Modulations of protease activated receptors |
01/06/2015 | US8927458 Herbicide triazolylpyridine ketones |
01/06/2015 | CA2694621C Novel serotonergic modulators |
01/06/2015 | CA2663376C N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same |
01/06/2015 | CA2610795C 3-arylidene-anabaseine compounds as alpha 7 nicotitnic receptor selective ligands |
01/01/2015 | US20150005503 Method for preparing 2-aminobenzamide derivatives |
01/01/2015 | US20150005494 Processes for preparing indoles |
01/01/2015 | US20150005350 Administration of ethyl 3-[(2--1-methyl-1h-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionate |
01/01/2015 | US20150005346 Allosteric modulators of cb1 cannabinoid receptors |
01/01/2015 | US20150005345 Benzhydrol-pyrazole derivatives having kinase inhibitory activity and uses thereof |
01/01/2015 | US20150005342 Hepatitis C Virus Inhibitors |
01/01/2015 | US20150005328 Oximes For Treatment Of Peripheral And Central Nervous System Exposure to Acetyl Cholinesterase Inhibitors |
01/01/2015 | US20150005319 Macrocyclic compounds for modulating il-17 |
01/01/2015 | US20150005315 1-substituted 4-arylpiperazine as kappa opioid receptor antagonists |
01/01/2015 | US20150005313 Heteroaromatic compounds and their use as dopamine d1 ligands |
01/01/2015 | US20150005308 Novel heteroarylamide derivatives having antiandrogenic properties |
01/01/2015 | US20150005303 5-substituted isoindoline compounds |
01/01/2015 | US20150005300 Pyridazinone compounds and methods for the treatment of cystic fibrosis |
01/01/2015 | US20150005297 2,4-Pyrimidinediamine Compounds and Their Uses |
01/01/2015 | US20150005296 Compounds, compositions and methods |
01/01/2015 | US20150005295 4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis b |
01/01/2015 | US20150005294 Azaheterocyclic compounds |
01/01/2015 | US20150005293 5-Membered Heterocyclic Amides And Related Compounds |
01/01/2015 | US20150005287 Quinolone compound |
01/01/2015 | US20150005283 Antiviral compounds |
01/01/2015 | US20150005281 Pyrimidine-2,4-diamine derivatives as kinase inhibitors |
01/01/2015 | US20150005279 Primary carboxamides as btk inhibitors |
01/01/2015 | US20150005278 Sulfoximine substituted quinazolines for pharmaceutical compositions |
01/01/2015 | US20150005277 Protein Kinase Inhibitors and Uses Thereof |
01/01/2015 | US20150005276 1,2,4-triazine-4-amine derivatives |
01/01/2015 | US20150005257 Arylalkyloxy pyrimidine derivative, pesticide for agricultural and horticultural use containing arylalkyloxy pyrimidine derivative as active ingredient, and use of same |
01/01/2015 | US20150005232 Indazole derivatives |
01/01/2015 | US20150005165 Substituted picolinic acids and pyrimidine-4-carboxylic acids, method for the production thereof and use thereof as herbicides and plant growth regulators |
01/01/2015 | US20150004666 Metalloenzyme inhibitor compounds |
01/01/2015 | US20150004181 Benzazole Derivatives as Histamine H4 Receptor Ligands |
12/31/2014 | CN104254529A 新有机电致发光化合物和包含该化合物的有机电致发光器件 The new compounds and organic electroluminescent compound comprising the organic electroluminescent device |
12/31/2014 | CN104254528A 抗菌的喹啉衍生物 Antibacterial quinoline derivatives |
12/31/2014 | CN104254527A 抗菌的喹啉衍生物 Antibacterial quinoline derivatives |
12/31/2014 | CN104254526A 针对结核病的新的抗分枝杆菌药物 For a new anti-tuberculosis mycobacterial drugs |
12/31/2014 | CN104254522A 作为trpv3调节剂的甲醇衍生物 As modulators of the carbinol derivative trpv3 |
12/31/2014 | CN104250243A 一种埃索美拉唑镁二水合物a晶型的制备方法 One kind of esomeprazole magnesium dihydrate a crystal preparation |
12/31/2014 | CN103204843B 结晶型艾普拉唑钠乙醇化物及其制备方法 Ilaprazole crystalline sodium ethanolate its preparation method |
12/31/2014 | CN102844304B 含氮杂环化合物以及农园艺用杀菌剂 Nitrogen-containing heterocyclic compounds, and agricultural and horticultural fungicide |
12/31/2014 | CN102421753B 制备吡咯化合物的方法 The method of preparation of an azole compound |
12/31/2014 | CN102369189B 氟喹诺酮羧酸分子晶体 Fluoroquinolone carboxylic acid molecular crystals |
12/31/2014 | CN102007118B 吡咯烷酮葡糖激酶激活剂 Pyrrolidone glucokinase activators |
12/30/2014 | US8921568 Iminosugars and their applications |
12/30/2014 | US8921567 Process for preparing N-substituted 1H-pyrazole-5-carbonylchloride compounds |
12/30/2014 | US8921566 Methods for the preparation of charged crosslinkers |
12/30/2014 | US8921563 1-[(4-hydroxypiperidin-4-yl)methyl]pyridin-2(1H)-one derivatives, preparation methods and uses thereof |
12/30/2014 | US8921562 Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors |
12/30/2014 | US8921559 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of CCR2 |
12/30/2014 | US8921550 Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives |
12/30/2014 | US8921547 Modulators of TNF-α signaling |
12/30/2014 | US8921514 Anti-viral compounds |
12/30/2014 | US8921405 Compounds |
12/30/2014 | US8921402 Substituted pyrazoles as estrogen receptor ligands |
12/30/2014 | US8921401 Pyrazole compounds, compositions and methods for treatment of degenerative diseases and disorders |
12/30/2014 | US8921400 Arthropodicidal anthranilamides |
12/30/2014 | US8921398 N-cyclopropyl-N-piperidinyl-amide derivatives, pharmaceutical compositions and uses thereof |
12/30/2014 | US8921396 Crystalline freebase forms of a biphenyl compound |
12/30/2014 | US8921395 Crystalline forms of a biphenyl compound |
12/30/2014 | US8921394 Prolylcarboxypeptidase inhibitors |
12/30/2014 | US8921385 5-substituted quinazolinone derivatives and compositions comprising and methods of using the same |
12/30/2014 | US8921378 Androgen receptor modulating carboxamides |
12/30/2014 | US8921373 Compounds having TRPV1 antagonistic activity and uses thereof |
12/30/2014 | US8921372 Inhibitors of hepatitis C virus |
12/30/2014 | US8921371 Oligomer-protein tyrosine kinase inhibitor conjugates |
12/30/2014 | US8921370 Bicyclo[3.2.1]octyl amide derivatives and uses of same |
12/30/2014 | US8921369 Inhibitors of HCV NS5A |
12/30/2014 | US8921364 Modulators of calcium release-activated calcium channel |
12/30/2014 | US8921361 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes |
12/30/2014 | US8921357 Pyridazinone derivatives |
12/30/2014 | US8921350 Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders |
12/30/2014 | CA2730793C Azole compound |
12/30/2014 | CA2618479C Pyrazine derivatives and use as pi3k inhibitors |
12/25/2014 | US20140378684 Chemical Process for the Synthesis of 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline |
12/25/2014 | US20140378509 Pyrazolone derivatives as pde4 inhibitors |
12/25/2014 | US20140378484 Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses |
12/25/2014 | US20140378474 5-membered heteroarylcarboxamide derivatives as plasma kallikrein inhibitors |